| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | MAB38751-SP | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | MAB2349-SP | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | AF2349-SP | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-52586-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | MAB3875-SP | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-38901-25ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-23571-0.05mg | |||
![Western Blot: Vitronectin Antibody (ST49-02) [NBP2-67511] - Analysis of Vitronectin on different lysates using anti-Vitronectin antibody at 1/1,000 dilution. Positive control: Lane 1: Human liver Lane 2: Human serum](http://images.novusbio.com/fullsize/Vitronectin-Antibody-ST49-02-Western-Blot-NBP2-67511-img0009.jpg "Western Blot: Vitronectin Antibody (ST49-02) [NBP2-67511] - Analysis of Vitronectin on different lysates using anti-Vitronectin antibody at 1/1,000 dilution. Positive control: Lane 1: Human liver Lane 2: Human serum")
![Immunocytochemistry/Immunofluorescence: Vitronectin Antibody (ST49-02) [NBP2-67511] - Staining Vitronectin in MCF-7 cells (green). The nuclear counter stain is DAPI (blue). Cells were fixed in paraformaldehyde, permeabilised with 0.25% Triton X100/PBS.](http://images.novusbio.com/fullsize/Vitronectin-Antibody-ST49-02-Immunocytochemistry-Immunofluorescence-NBP2-67511-img0004.jpg)
![Immunohistochemistry-Paraffin: Vitronectin Antibody (ST49-02) [NBP2-67511] - Immunohistochemical analysis of paraffin-embedded human skin tissue using anti-Vitronectin antibody. The section was pre-treated using heat mediated antigen retrieval with Tris-EDTA buffer (pH 8.0-8.4) for 20 minutes. The tissues were blocked in 5% BSA for 30 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (ET1609-39, 1/200) for 30 minutes at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX.](http://images.novusbio.com/fullsize/Vitronectin-Antibody-ST49-02-Immunohistochemistry-Paraffin-NBP2-67511-img0011.jpg)
![Immunocytochemistry/Immunofluorescence: Vitronectin Antibody (ST49-02) [NBP2-67511] - Staining Vitronectin in A431 cells (green). The nuclear counter stain is DAPI (blue). Cells were fixed in paraformaldehyde, permeabilised with 0.25% Triton X100/PBS.](http://images.novusbio.com/fullsize/Vitronectin-Antibody-ST49-02-Immunocytochemistry-Immunofluorescence-NBP2-67511-img0001.jpg)
![Immunocytochemistry/Immunofluorescence: Vitronectin Antibody (ST49-02) [NBP2-67511] - Staining Vitronectin in A549 cells (green). The nuclear counter stain is DAPI (blue). Cells were fixed in paraformaldehyde, permeabilised with 0.25% Triton X100/PBS.](http://images.novusbio.com/fullsize/Vitronectin-Antibody-ST49-02-Immunocytochemistry-Immunofluorescence-NBP2-67511-img0002.jpg)
![Immunocytochemistry/Immunofluorescence: Vitronectin Antibody (ST49-02) [NBP2-67511] - Staining Vitronectin in HepG2 cells (green). The nuclear counter stain is DAPI (blue). Cells were fixed in paraformaldehyde, permeabilised with 0.25% Triton X100/PBS.](http://images.novusbio.com/fullsize/Vitronectin-Antibody-ST49-02-Immunocytochemistry-Immunofluorescence-NBP2-67511-img0003.jpg)
![Immunohistochemistry-Paraffin: Vitronectin Antibody (ST49-02) [NBP2-67511] - Analysis of paraffin-embedded human liver cancer tissue using anti-Vitronectin antibody. Counter stained with hematoxylin.](http://images.novusbio.com/fullsize/Vitronectin-Antibody-ST49-02-Immunohistochemistry-Paraffin-NBP2-67511-img0005.jpg)
![Immunohistochemistry-Paraffin: Vitronectin Antibody (ST49-02) [NBP2-67511] - Analysis of paraffin-embedded human liver tissue using anti-Vitronectin antibody. Counter stained with hematoxylin.](http://images.novusbio.com/fullsize/Vitronectin-Antibody-ST49-02-Immunohistochemistry-Paraffin-NBP2-67511-img0006.jpg)
![Immunohistochemistry-Paraffin: Vitronectin Antibody (ST49-02) [NBP2-67511] - Analysis of paraffin-embedded mouse liver tissue using anti-Vitronectin antibody. Counter stained with hematoxylin.](http://images.novusbio.com/fullsize/Vitronectin-Antibody-ST49-02-Immunohistochemistry-Paraffin-NBP2-67511-img0007.jpg)
![Immunohistochemistry-Paraffin: Vitronectin Antibody (ST49-02) [NBP2-67511] - Analysis of paraffin-embedded mouse skin tissue using anti-Vitronectin antibody. Counter stained with hematoxylin.](http://images.novusbio.com/fullsize/Vitronectin-Antibody-ST49-02-Immunohistochemistry-Paraffin-NBP2-67511-img0008.jpg)
![Immunohistochemistry-Paraffin: Vitronectin Antibody (ST49-02) [NBP2-67511] - Immunohistochemical analysis of paraffin-embedded human liver tissue using anti-Vitronectin antibody. The section was pre-treated using heat mediated antigen retrieval with Tris-EDTA buffer (pH 8.0-8.4) for 20 minutes. The tissues were blocked in 5% BSA for 30 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (ET1609-39, 1/50) for 30 minutes at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX.](http://images.novusbio.com/fullsize/Vitronectin-Antibody-ST49-02-Immunohistochemistry-Paraffin-NBP2-67511-img0010.jpg)
![Western Blot: Vitronectin Antibody [NBP2-20866] - Proteomics analysis of losartan-mediated reversion of early fibrotic RDEB changes.Bar graph show abundance of representative proteins normalized by losartan treatment. Mean +/- S.E.M. (LFQ intensity) of groups of individual mice (wild-type, untreated, & losartan-treated C7-hypomorphic mice). Unpaired t-test calculated significance. Abundance of Lrg1: *P-value C7-hypomorphic vs. losartan-treated C7-hypomorphic mice = 0.022; abundance of serpin f2: **P-value untreated C7-hypomorphic vs. losartan-treated C7-hypomorphic mice = 0.0084; abundance of vitronectin: **P-value untreated C7-hypomorphic vs. losartan-treated C7-hypomorphic mice = 0.0094. Western blots of skin lysates from wild-type, untreated C7-hypomorphic, & 7-week losartan-treated C7-hypomorphic mice not used for proteomics. Image collected & cropped by CiteAb from the following publication (www.onlinelibrary.wiley.com/doi/10.15252/emmm.201505061) licensed under a CC-BY license.](http://images.novusbio.com/fullsize/Vitronectin-Antibody-Western-Blot-NBP2-20866-img0009.jpg "<b>Biological Strategies Validation. </b>Western Blot: Vitronectin Antibody [NBP2-20866] - Proteomics analysis of losartan-mediated reversion of early fibrotic RDEB changes.Bar graph show abundance of representative proteins normalized by losartan treatment. Mean +/- S.E.M. (LFQ intensity) of groups of individual mice (wild-type, untreated, & losartan-treated C7-hypomorphic mice). Unpaired t-test calculated significance. Abundance of Lrg1: *P-value C7-hypomorphic vs. losartan-treated C7-hypomorphic mice = 0.022; abundance of serpin f2: **P-value untreated C7-hypomorphic vs. losartan-treated C7-hypomorphic mice = 0.0084; abundance of vitronectin: **P-value untreated C7-hypomorphic vs. losartan-treated C7-hypomorphic mice = 0.0094. Western blots of skin lysates from wild-type, untreated C7-hypomorphic, & 7-week losartan-treated C7-hypomorphic mice not used for proteomics. Image collected & cropped by CiteAb from the following publication (www.onlinelibrary.wiley.com/doi/10.15252/emmm.201505061) licensed under a CC-BY license.")
![<b>Biological Strategies Validation. </b>Immunohistochemistry-Paraffin: Vitronectin Antibody [NBP2-20866] - Vitronectin antibody detects Vitronectin protein by immunohistochemical analysis. Sample: Paraffin-embedded human lung cancer. Vitronectin stained by Vitronectin antibody diluted at 1:1000.](http://images.novusbio.com/fullsize/Vitronectin-Antibody-Immunohistochemistry-Paraffin-NBP2-20866-img0008.jpg)
![Immunohistochemistry-Paraffin: Vitronectin Antibody [NBP2-20866] - Human colon carcinoma, using Vitronectin antibody at 1:500 dilution. Antigen Retrieval: Trilogy™ (EDTA based, pH 8.0) buffer, 15min.](http://images.novusbio.com/fullsize/Vitronectin-Antibody-Immunohistochemistry-Paraffin-NBP2-20866-img0003.jpg)
![Western Blot: Vitronectin Antibody [NBP2-20866] - HepG2 whole cell extract and conditioned medium (30 ug) were separated by 10% SDS-PAGE, and the membrane was blotted with Vitronectin antibody (NBP2-20866) diluted at 1:1000. The HRP-conjugated anti-rabbit IgG antibody was used to detect the primary antibody.](http://images.novusbio.com/fullsize/nbp2-20866_rabbit-polyclonal-vitronectin-antibody-910202420104489.jpg)
![Western Blot: Vitronectin Antibody (1G11E8) [NBP2-52586] - Analysis using VTN mAb against human VTN (AA: 20-199) recombinant protein. (Expected MW is 45.9 kDa)](http://images.novusbio.com/fullsize/Vitronectin-Antibody-1G11E8-Western-Blot-NBP2-52586-img0004.jpg "Western Blot: Vitronectin Antibody (1G11E8) [NBP2-52586] - Analysis using VTN mAb against human VTN (AA: 20-199) recombinant protein. (Expected MW is 45.9 kDa)")
![Immunohistochemistry-Paraffin: Vitronectin Antibody (1G11E8) [NBP2-52586] - Analysis of paraffin-embedded liver cancer tissues using VTN mouse mAb with DAB staining.](http://images.novusbio.com/fullsize/Vitronectin-Antibody-1G11E8-Immunohistochemistry-Paraffin-NBP2-52586-img0003.jpg)
![Flow Cytometry: Vitronectin Antibody (1G11E8) [NBP2-52586] - Analysis of Hela cells using VTN mouse mAb (green) and negative control (red).](http://images.novusbio.com/fullsize/Vitronectin-Antibody-1G11E8-Flow-Cytometry-NBP2-52586-img0001.jpg)
![Western Blot: Vitronectin Antibody (1G11E8) [NBP2-52586] - Analysis using VTN mAb against HEK293 (1) and VTN (AA: 20-199)-hIgGFc transfected HEK293 (2) cell lysate.](http://images.novusbio.com/fullsize/Vitronectin-Antibody-1G11E8-Western-Blot-NBP2-52586-img0005.jpg)
![Immunohistochemistry-Paraffin: Vitronectin Antibody (1G11E8) [NBP2-52586] - Analysis of paraffin-embedded cervical cancer tissues using VTN mouse mAb with DAB staining.](http://images.novusbio.com/fullsize/Vitronectin-Antibody-1G11E8-Immunohistochemistry-Paraffin-NBP2-52586-img0002.jpg)
![ELISA: Vitronectin Antibody (1G11E8) [NBP2-52586] - Black line: Control Antigen (100 ng); Purple line: Antigen(10ng); Blue line: Antigen (50 ng); Red line: Antigen (100 ng);](http://images.novusbio.com/fullsize/Vitronectin-Antibody-1G11E8-Flow-Cytometry-NBP2-52586-img0006.jpg)
![Immunocytochemistry/Immunofluorescence: Vitronectin Antibody [NBP2-38901] - Staining of human cell line CACO-2 shows localization to endoplasmic reticulum & vesicles.](http://images.novusbio.com/fullsize/Vitronectin-Antibody-Immunocytochemistry-Immunofluorescence-NBP2-38901-img0003.jpg "Immunocytochemistry/Immunofluorescence: Vitronectin Antibody [NBP2-38901] - Staining of human cell line CACO-2 shows localization to endoplasmic reticulum & vesicles.")
![Immunohistochemistry-Paraffin: Vitronectin Antibody [NBP2-38901] - Staining of human kidney shows distinct positivity in plasma.](http://images.novusbio.com/fullsize/Vitronectin-Antibody-Immunohistochemistry-NBP2-38901-img0002.jpg)